China Sxt Pharmaceuticals (SXTC) said Monday that it has regained compliance with Nasdaq's minimum bid price listing requirement.
The pharmaceutical company said it regained compliance as its stock price was at least $1 a share for 10 consecutive business days ending March 12.
Shares were up 1.8% in early trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.